ASAPF (Aurora Spine) Other Financing: $0.00 Mil (TTM As of Mar. 2026)


ASAPF Aurora Spine Corp ASAPF
40 GF Score
Price $0.16
GF Value $0.22
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Aurora Spine Other Financing?

Aurora Spine ASAPF 40 Other Financing is $0.00 Mil as of Mar. 2026. GuruFocus rates ASAPF with a GF Score™ of 40/100 and a GF Value™ of $0.22 (Possible Value Trap). The stock has 4 warning signs investors should review.

Aurora Spine's Other Financing for the three months ended in Mar. 2026 was $0.00 Mil.

Aurora Spine's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Aurora Spine Other Financing Historical Data

* Premium members only.

The historical data trend for Aurora Spine's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Spine Other Financing Chart

Aurora Spine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.82 0.10 0.67 0.00 0.07

Aurora Spine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.00 0.00 0.00 0.00
ASAPF
40GF Score
Aurora Spine Corp ASAPF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Spine Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.00 Mil mean?
Aurora Spine (ASAPF) has a Other Financing of $0.00 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Aurora Spine and its competitors.
Is Aurora Spine's Other Financing too high?
Aurora Spine's current Other Financing is $0.00 Mil. Overall, Aurora Spine has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Other Financing compare to ABT and SYK?
Aurora Spine's Other Financing of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Aurora Spine and its competitors. Aurora Spine's current Other Financing is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.22, compared to a current price of $0.16 — trading 29.5% below its estimated fair value. The current Other Financing is $0.00 Mil. Aurora Spine's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Other Financing is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Spine (ASAPF) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued. The current stock price of $0.16 is trading 29.5% below its estimated GF Value™ of $0.22. GuruFocus considers Aurora Spine to be Possible Value Trap.

Key valuation signals for ASAPF:

  • Other Financing: $0.00 Mil
  • GF Value™: $0.22 vs. price of $0.16 (29.5% below fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Spine Business Description

Other Exchanges ASG:Canada
Address 20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
40GF Score

Get the complete analysis for ASAPF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price
$0.22
GF Value